Antiplatelet drugs, coronary stents, and non-cardiac surgery
نویسندگان
چکیده
منابع مشابه
Guidelines for the management of antiplatelet therapy in patients with coronary stents undergoing non-cardiac surgery.
C tainty regarding the risks of stent thrombosis in individual patients, and in particular how to balance this risk against that of surgical complications if antiplatelet therapy is continued throughout the perioperative period. This guideline provides consensus advice regarding (RACS), the Australian and New Zealand College of Anaesthetists (ANZCA), the Royal Australasian College of Dental Sur...
متن کاملUrological surgery and antiplatelet drugs after cardiac and cerebrovascular accidents.
PURPOSE The perioperative treatment of patients on dual antiplatelet therapy after myocardial infarction, cerebrovascular event or coronary stent implantation represents an increasingly frequent issue for urologists and anesthesiologists. We assess the current scientific evidence and propose strategies concerning treatment of these patients. MATERIALS AND METHODS A MEDLINE and PubMed search w...
متن کاملPerioperative Management of Antiplatelet-Drugs in Cardiac Surgery
The management of coronary patients scheduled for a coronary artery bypass grafting (CABG), who are receiving one or more antiplatelet drugs, is plenty of controversies. It has been shown that withdrawal of antiplatelet drugs is associated with an increased risk of a thrombotic event, but surgery under an altered platelet function also means an increased risk of bleeding in the perioperative pe...
متن کاملPerioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies.
Optimal perioperative antiplatelet therapy in patients with coronary stents undergoing surgery still remains poorly defined and a matter of debate among cardiologists, surgeons and anaesthesiologists. Surgery represents one of the most common reasons for premature antiplatelet therapy discontinuation, which is associated with a significant increase in mortality and major adverse cardiac events,...
متن کاملCoronary stents and non-cardiac surgery: to bridge or not to bridge?
Haemost 2015; 114: 423-431. Patients with coronary stents need antiplatelet therapy to reduce the risk of stent thrombosis. The standard therapy is lifelong low-dose aspirin with supplementary P2Y12-inhibitor treatment during the first months. In patients who have suffered from an acute coronary syndrome (ACS), the P2Y12-inhibitor is usually given for 12 months (1–3). In these patients, the new...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Continuing Education in Anaesthesia Critical Care & Pain
سال: 2010
ISSN: 1743-1816
DOI: 10.1093/bjaceaccp/mkq038